✦ LIBER ✦

Antitumor and Immunomodulating Effects of a Fragment of HL-60 Cell Differentiation Factor in Mice with Lewis Pulmonary Carcinoma

✍ Scribed by G. M. Sysoeva; V. A. Fadina; E. D. Danilenko; V. V. Samukov; I. A. Kostanyan; V. I. Masycheva

Book ID: 106358265
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 221 KB
Volume: 147
Category: Article
ISSN: 0007-4888
DOI: 10.1007/s10517-009-0481-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

415 POSTER Antitumor activity of fragmen

415 POSTER Antitumor activity of fragments of the HL-60 cell differentiation factor in mice with Lewis lung carcinoma

✍ G.M. Sysoeva; V.A. Fadina; E.D. Danilenko; V.V. Samukov; I.A. Kostanyan; V.I. Ma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Antitumor and antimetastatic effects of

Antitumor and antimetastatic effects of betulonic acid amides in mice with transplantable Lewis carcinoma

✍ I. V. Sorokina; T. G. Tolstikova; N. A. Zhukova; N. I. Petrenko; N. V. Uzenkova; 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 296 KB

Potentiating antitumor effects of a comb

Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice

✍ Adam Giermasz; Marcin Makowski; Ewa Kozłowska; Dominika Nowis; Małgorzata Maj; A 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 194 KB 👁 2 views

## Abstract Lovastatin, the drug used for the treatment of hypercholesterolemia, has previously been reported to exert antitumor activity in experimental murine models. Butyrate and butyric acid derivatives are well known to induce differentiation and apoptosis of tumour cells and also have recentl

Effect of Z-100, an immunomodulator extr

Effect of Z-100, an immunomodulator extracted from human type tubercle bacilli, on the pulmonary metastases of lewis lung carcinoma in attempt to regulate suppressor T cells and suppressor factor, IL-4

✍ Yutaka Emori; Hidetaka Sasaki; Yoshiro Hayashi; Kikuo Nomoto 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 534 KB

Therapeutic effects of monoclonal antibo

Therapeutic effects of monoclonal antibody g250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts

✍ J. van Dijk; H. Uemura; A. J. M. C. Beniers; W. P. Peelen; S. Th. Zegveld; G. J. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 1015 KB

Because renal-cell carcinoma (RCC) is considered relatively resistant to radio-and chemotherapy, RCC patients may benefit from new treatment modalities, e.g. immunotherapy. In vitro and in vivo studies suggest that combinations of cytokines such as interferon y or interferon a (IFN-y, IFN-a) and tum